|
Melatonin-estrogen interactions in breast cancer
|
01 January 2014 |
|
Rationale for the use of somatostatin analogs as antitumor agents
|
30 December 2013 |
|
Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells
|
29 December 2013 |
|
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition
|
28 December 2013 |
|
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation
|
25 December 2013 |
|
Growth hormone and colorectal carcinoma: localization of receptors
|
25 December 2013 |
|
Detection of the retinoic acid-regulated genes in a RTBM1 neuroblastoma cell line using cDNA microarray
|
16 December 2013 |
|
Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment
|
13 December 2013 |
|
Growth inhibitory effect of the somatostatin structural derivative (TT-232) on leukemia models
|
13 December 2013 |
|
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium
|
13 December 2013 |